| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUR.58.3.411 |
| P698 | PubMed publication ID | 11255444 |
| P2093 | author name string | Berent S | |
| Foster NL | |||
| Giordani B | |||
| Bozoki A | |||
| Heidebrink JL | |||
| P433 | issue | 3 | |
| P921 | main subject | mild cognitive impairment | Q1472703 |
| dementia | Q83030 | ||
| P304 | page(s) | 411-416 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. | |
| P478 | volume | 58 |
| Q35821058 | A comparison of non-homogeneous Markov regression models with application to Alzheimer's disease progression |
| Q50781330 | A comparison of screening tools for the assessment of mild cognitive impairment: preliminary findings. |
| Q50775749 | A longitudinal study regarding conversion from mild memory impairment to dementia in a Japanese community. |
| Q33575564 | A new measure of visual location learning and memory: development and psychometric properties for the Brown Location Test (BLT). |
| Q36660799 | A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease |
| Q38403223 | Accuracy of a Brief Neuropsychological Battery for the Diagnosis of Dementia and Mild Cognitive Impairment: An Analysis of the NEDICES Cohort |
| Q35236545 | Age-related mild cognitive deficit: a ready-to-use concept? |
| Q51983653 | Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. |
| Q38446119 | Amnestic multiple cognitive domains impairment and periventricular white matter hyperintensities are independently predictive factors progression to dementia in mild cognitive impairment |
| Q51982966 | Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. |
| Q34021001 | Application study of quick cognitive screening test in identifying mild cognitive impairment |
| Q34678734 | Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging |
| Q48000763 | Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study. |
| Q37073874 | Brain event-related potentials: diagnosing early-stage Alzheimer's disease |
| Q51994676 | CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease. |
| Q38492750 | Capacity of the Catalan and Spanish versions of the Bilingual Aphasia Test to distinguish between healthy aging, mild cognitive impairment and Alzheimer's disease |
| Q64230129 | Central Auditory Processing Tests as Diagnostic Tools for the Early Identification of Elderly Individuals with Mild Cognitive Impairment |
| Q59813433 | Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment |
| Q42253144 | Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study |
| Q33953312 | Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment |
| Q64911752 | Comparison of the value of Mini-Cog and MMSE screening in the rapid identification of Chinese outpatients with mild cognitive impairment. |
| Q50747975 | Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease. |
| Q47593264 | Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease |
| Q43956384 | Contributions of the Computer-Administered Neuropsychological Screen for Mild Cognitive Impairment (CANS-MCI) for the diagnosis of MCI in Brazil. |
| Q46795217 | Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors |
| Q35009746 | Current treatments and therapeutic targets in Alzheimer's disease |
| Q40563823 | Decline in learning ability best predicts future dementia type: the Freedom House Study |
| Q50886837 | Decline in verbal memory in non-demented older adults. |
| Q38129323 | Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis |
| Q36787352 | Dementia syndromes: evaluation and treatment |
| Q34463982 | Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study |
| Q33942367 | Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test |
| Q33711721 | Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease. |
| Q33899796 | Differential FDDNP PET patterns in nondemented middle-aged and older adults |
| Q33511724 | Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment |
| Q51052146 | Distinguishing Alzheimer's disease from vascular dementia: an exploration of five cognitive domains. |
| Q30770505 | Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging |
| Q37347911 | Ecological assessment of executive functions in mild cognitive impairment and mild Alzheimer's disease |
| Q49668024 | Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer's disease in Japan |
| Q51889292 | Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. |
| Q50779605 | Estimation of the risk of conversion of mild cognitive impairment of Alzheimer type to Alzheimer's disease in a south Brazilian population-based elderly cohort: the PALA study. |
| Q38407921 | Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: a very-long-term follow-up study |
| Q36649785 | Expanding the usefulness of Interpersonal Psychotherapy (IPT) for depressed elders with co-morbid cognitive impairment |
| Q57253837 | Feasibility of treating mild cognitive impairment withcholinesterase inhibitors |
| Q73310178 | Five-Year Outcomes for Dementia Defined Solely by Neuropsychological Test Performance |
| Q90291507 | Frequency and associated factors of amnestic mild cognitive impairment at four senior citizen clubs in Lima, Peru |
| Q36874130 | Gene-Environment Interplay in Physical, Psychological, and Cognitive Domains in Mid to Late Adulthood: Is APOE a Variability Gene? |
| Q33881832 | Group-Level Progressive Alterations in Brain Connectivity Patterns Revealed by Diffusion-Tensor Brain Networks across Severity Stages in Alzheimer's Disease |
| Q47552148 | HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing |
| Q38679995 | Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment. |
| Q34148188 | Heterogeneity of cognitive trajectories in diverse older persons |
| Q37399368 | Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. |
| Q39760818 | Impaired digit span can predict further cognitive decline in older people with subjective memory complaint: a preliminary result |
| Q51952876 | Interplay between memory and executive functions in normal and pathological aging. |
| Q39714378 | Italian Project on Epidemiology of Alzheimer's disease (I.PR.E.A.): study design and methodology of cross-sectional survey |
| Q91864326 | Jidong cognitive impairment cohort study: objectives, design, and baseline screening |
| Q22248003 | Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review |
| Q51954000 | Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. |
| Q51108602 | Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features. |
| Q39250512 | Lowered performance in working memory and attentional sub-processes are most prominent in multi-domain amnestic mild cognitive impairment subtypes. |
| Q36141850 | Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. |
| Q35677204 | Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia |
| Q37390862 | Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease |
| Q38461191 | Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease |
| Q37001167 | Mild cognitive dysfunction: an epidemiological perspective with an emphasis on African Americans |
| Q53286368 | Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria. |
| Q34976854 | Mild cognitive impairment--a review of prevalence, incidence and outcome according to current approaches |
| Q35483148 | Mild cognitive impairment: a cross-national comparison |
| Q37139165 | Mild cognitive impairment: a review and nursing implications |
| Q51993159 | Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. |
| Q38409088 | Mild cognitive impairment: deficits in cognitive domains other than memory. |
| Q35764334 | Mild cognitive impairment: focus on diagnosis. |
| Q35236843 | Mild cognitive impairment: historical development and summary of research |
| Q73666737 | Mild cognitive impairment: prevalence and predictive validity according to current approaches |
| Q35172333 | Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment |
| Q46785813 | Mild cognitive impairment: to treat or not to treat |
| Q22242620 | Multiple cognitive deficits during the transition to Alzheimer's disease |
| Q37073649 | Multiple cognitive deficits in amnestic mild cognitive impairment |
| Q30532472 | Naturalistic assessment of everyday functioning in individuals with mild cognitive impairment: the day-out task |
| Q42062975 | Neurocognitive and Behavioral Indexes for Identifying the Amnestic Subtypes of Mild Cognitive Impairment |
| Q37158949 | Neuronal LR11/sorLA expression is reduced in mild cognitive impairment |
| Q38391369 | Neuropsychological and neuroimaging characteristics of amnestic mild cognitive impairment subtypes: a selective overview |
| Q35038881 | Neuropsychological assessment in the diagnosis of Alzheimer's disease |
| Q37951806 | Neuropsychological assessment of patients with dementing illness |
| Q37217932 | Neuropsychological characterization of mild cognitive impairment |
| Q22251334 | Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease |
| Q36026952 | Neuropsychological function in nondemented carriers of presenilin-1 mutations. |
| Q51980686 | Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease. |
| Q37390851 | Neuropsychological strategies for detecting early dementia |
| Q34714070 | Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. |
| Q51831281 | Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm. |
| Q36445708 | P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia |
| Q43473235 | Patterns of Cognitive Decline, Conversion Rates, and Predictive Validity for 3 Models of MCI |
| Q37436872 | Patterns of mild cognitive impairment after treatment of depression in the elderly |
| Q33621777 | Persistence of neuropsychological testing deficits in mild cognitive impairment |
| Q35930947 | Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification |
| Q38392741 | Predicting rapid clinical progression in amnestic mild cognitive impairment |
| Q36253368 | Prevention of dementia |
| Q51953447 | Production and identification repetition priming in amnestic mild cognitive impairment. |
| Q31036429 | Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort. |
| Q33824788 | Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts |
| Q37902968 | Prospective memory impairment in mild cognitive impairment: an analytical review |
| Q37261182 | Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years |
| Q57834214 | Quantitative and Qualitative Impairments in Semantic Fluency, but not Phonetic Fluency, as a Potential Risk Factor for Alzheimer's Disease |
| Q38428166 | Reducing false positive diagnoses in mild cognitive impairment: the importance of comprehensive neuropsychological assessment |
| Q44632428 | Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. |
| Q51973983 | Risk factors and early signs of Alzheimer's disease in a family study sample. Risk of AD. |
| Q38878412 | Risk factors for disability progression among Japanese long-term care service users: A 3-year prospective cohort study |
| Q40470597 | Selective memory impairment on an adapted Mini-Mental State Examination increases risk of future dementia. |
| Q35017028 | Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery |
| Q35820760 | Self-perceived memory loss is associated with an increased risk of hip fracture in the elderly: a population-based NOREPOS cohort study |
| Q35676774 | Spatial navigation deficit in amnestic mild cognitive impairment |
| Q33621276 | Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period. |
| Q31124464 | Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links |
| Q45021886 | Subtle memory decline over 12 months in mild cognitive impairment. |
| Q58141235 | Test–retest discourse performance of individuals with mild cognitive impairment |
| Q48420549 | The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening |
| Q38374227 | The Cambridge Semantic Memory Test Battery: detection of semantic deficits in semantic dementia and Alzheimer's disease. |
| Q33625660 | The Combination of Dysexecutive and Amnestic Deficits Strongly Predicts Conversion to Dementia in Young Mild Cognitive Impairment Patients: A Report from the Gothenburg-Oslo MCI Study |
| Q57169446 | The Face-Name Associative Memory Test as a Tool for Early Diagnosis of Alzheimer's Disease |
| Q35484657 | The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition |
| Q59811244 | The Interaction Effect between Blood Stasis Constitution and Atherosclerotic Factors on Cognitive Impairment in Elderly People |
| Q47626911 | The prevalence and progression of mild cognitive impairment among clinic and community populations: a systematic review and meta-analysis. |
| Q51938128 | The prevalence of "cognitive impairment no dementia" in community-dwelling elderly: a pilot study. |
| Q37988692 | The profile of executive functioning in amnestic mild cognitive impairment: disproportionate deficits in inhibitory control |
| Q50793432 | The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. |
| Q103805295 | Trajectories of depressive symptoms and associated patterns of cognitive decline |
| Q51951955 | Usefulness of repeated presentation of Mini-Mental State Examination as a diagnostic procedure--a population-based study. |
| Q24792850 | Validity of a novel computerized cognitive battery for mild cognitive impairment |
| Q51998534 | Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment. |
| Q48163290 | Vascular risk factors and white matter hyperintensities in patients with amnestic mild cognitive impairment |
| Q48717348 | Voxel based morphometry features and follow-up of amnestic patients at high risk for Alzheimer's disease conversion |
Search more.